Using lidocaine to manage pain after thoracoscopic surgery in young children
The Effect of Intraoperative Intravenous Lidocaine Infusion on Postoperative Pain and Recovery in Children (< 7 Years Old) Undergoing Thoracoscopic Surgery:Prospective, Randomized Controlled Trial
This study tests if giving lidocaine during surgery can help young children under 7 feel less pain and recover faster after thoracoscopic surgery.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Enrollment | 80 (estimated) |
| Ages | 6 Months to 7 Years |
| Sex | All |
| Sponsor | Seoul National University Hospital Academic / other |
| Locations | 1 site (Seoul) |
| Trial ID | NCT06710405 on ClinicalTrials.gov |
What this trial studies
This study investigates the effectiveness of administering intravenous lidocaine during surgery to improve postoperative pain management and recovery in children under 7 years old undergoing thoracoscopic pulmonary resection. The approach involves comparing the effects of lidocaine infusion against a saline placebo. The goal is to determine if lidocaine can significantly reduce pain and enhance recovery times in this pediatric population.
Who should consider this trial
Good fit: Ideal candidates are pediatric patients under 7 years old who are scheduled for thoracoscopic pulmonary resection.
Not a fit: Patients with cardiac dysfunction, liver or kidney issues, or hypersensitivity to local anesthetics may not benefit from this study.
Why it matters
Potential benefit: If successful, this could lead to improved pain management and faster recovery for young children after thoracoscopic surgery.
How similar studies have performed: Other studies have shown promising results with lidocaine for pain management, suggesting this approach may be beneficial.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Pediatric patients aged under 7 years undergoing thoracoscopic pulmonary resection Exclusion Criteria: * cardiac dysfunction requiring vasopressors or inotropic agents * atrioventricular block or bradycardia * Liver or kidney dysfunction * Hypersensitivity to local anesthetics
Where this trial is running
Seoul
- Seoul National University Hospital — Seoul, South Korea (Recruiting)
Study contacts
- Study coordinator: Ji-Hyun Lee, MD, PhD
- Email: muslab6@snu.ac.kr
- Phone: 82-2-2072-3661
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.